user

Gefitinib maintenance in stage III non-small-cell lung cancer

被引：3
|
作者：
Stewart, David J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 29期
关键词：
D O I：
10.1200/JCO.2008.18.7625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4849 / 4850
页数：3
相关论文
共 50 条
  • [21] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer REPLY
    Cataldo, Vince D.
    Gibbons, Don L.
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2368 - 2368
  • [22] Biomarkers of response to gefitinib in non-small-cell lung cancer
    David P Carbone
    Nature Clinical Practice Oncology, 2004, 1 : 66 - 67
  • [23] Gefitinib therapy for advanced non-small-cell lung cancer
    Liu, CY
    Seen, S
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1644 - 1653
  • [24] Gefitinib or docetaxel in advanced non-small-cell lung cancer
    Cullen, Michael
    Thatcher, Nicholas
    LANCET, 2008, 372 (9652): : 1785 - 1786
  • [25] Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline
    Daly, Megan E.
    Singh, Navneet
    Ismaila, Nofisat
    Antonoff, Mara B.
    Arenberg, Douglas A.
    Bradley, Jeffrey
    David, Elizabeth
    Detterbeck, Frank
    Fruh, Martin
    Gubens, Matthew A.
    Moore, Amy C.
    Padda, Sukhmani K.
    Patel, Jyoti D.
    Phillips, Tanyanika
    Qin, Angel
    Robinson, Clifford
    Simone, Charles B., II
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1356 - +
  • [26] Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
    Provencio, Mariano
    Nadal, Ernest
    Gonzalez-Larriba, Jose L.
    Martinez-Marti, Alex
    Bernabe, Reyes
    Bosch-Barrera, Joaquim
    Casal-Rubio, Joaquin
    Calvo, Virginia
    Insa, Amelia
    Ponce, Santiago
    Reguart, Noemi
    de Castro, Javier
    Mosquera, Joaquin
    Cobo, Manuel
    Aguilar, Andres
    Vivanco, Guillermo Lopez
    Camps, Carlos
    Lopez-Castro, Rafael
    Moran, Teresa
    Barneto, Isidoro
    Rodriguez-Abreu, Delvys
    Serna-Blasco, Roberto
    Benitez, Raquel
    Aguado de la Rosa, Carlos
    Palmero, Ramon
    Hernando-Trancho, Florentino
    Martin-Lopez, Javier
    Cruz-Bermudez, Alberto
    Massuti, Bartomeu
    Romero, Atocha
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (06): : 504 - 513
  • [27] Optimal therapy for uresectale stage III non-small-cell lung cancer
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5853 - 5855
  • [28] Issues at the cutting edge in stage III non-small-cell lung cancer
    Green, MR
    Lilenbaum, RC
    ANNALS OF ONCOLOGY, 1995, 6 : 33 - 36
  • [29] Quality of life with durvalumab in stage III non-small-cell lung cancer
    Anota, Amelie
    Westeel, Virginie
    LANCET ONCOLOGY, 2019, 20 (12): : 1619 - 1620
  • [30] The role of chemoradiotherapy in the treatment of stage III non-small-cell lung cancer
    Eberhardt, W
    Gauler, T
    Hepp, R
    Korfee, S
    Pöttgen, C
    Stamatis, G
    Stuschke, M
    ANNALS OF ONCOLOGY, 2004, 15 : 71 - 80
12345